JPL Wealth Management’s Biogen BIIB Stock Holding History

JPL Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	5 +2	+67%	+$383	﹤0.01%	1274
2026 Q1	$551	Buy	+3	New	+$553	﹤0.01%	1298

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JPL Wealth Management's BIIB Position: Q2 2026 in Review

JPL Wealth Management increased its Biogen (BIIB) stake by 67% in Q2 2026, buying an estimated $383 and bringing the position to 5 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

JPL Wealth Management first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

JPL Wealth Management held 5 shares of Biogen worth $1.08K as of Q2 2026.
JPL Wealth Management bought 2 Biogen shares in Q2 2026, an estimated $383.
Biogen made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1274 holding.
JPL Wealth Management first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.